Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug ...

Dr. Lotan graduated with high honors from the University of Texas at Austin and with honors from Baylor College of Medicine in Houston. He trained in general surgery and urology at UT Southwestern ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

Olivia Enietan, a doctoral student in chemistry and biochemistry, will participate in the prestigious 2025 Clinical and Translational Research Summer Course organized by the National Institutes of ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

UC Davis launches $25 million venture capital fund © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our ...

Some lawmakers and the Trump administration have criticized the government’s long-standing model for reimbursing universities ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

In light of recent federal research funding cuts, the Arthritis Foundation and CARRA each contributed an additional $100,000 to support the grant program this year. Meanwhile, demand for research ...